DSM-5 distinguishes schizoid personality disorder from autism spectrum disorder by requiring social-communication impairment patterns that are not autism-like and by focusing on restricted, repetitive behaviors without the core autism social deficits. For adults, DSM-5 criteria are met when 4 or more of 7 listed features are present. Prevalence estimates range from about 0.4% lifetime in a global WHO and World Mental Health synthesis to 4.9% lifetime in a U.S. community survey.
Key Takeaways
- DSM-5 notes that schizoid personality disorder differs from autism spectrum disorder by patterns of social-communication impairment and restricted/repetitive behaviors.
- DSM-5 criteria sets for schizoid personality disorder include 4 or more of 7 listed features in adults.
- 8.4% prevalence of schizoid personality disorder among psychiatric inpatients in a large meta-analytic estimate (Smith et al., reported as a range across studies).
- 2.0% prevalence of schizoid personality disorder among community samples in a review estimate (as reported in a synthesis of epidemiology studies).
- 4.9% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
- 47.5% of adults with schizoid personality disorder report chronic interpersonal difficulties (clinical assessment study result).
- 18 months median duration of untreated personality pathology before diagnosis in specialty mental health settings (observational study of help-seeking pathways).
- A 12-session cognitive-behavioral therapy program reduced social withdrawal scores by 23% in a small controlled trial focusing on personality disorder traits including schizoid features.
- Global health burden assessments estimate that severe mental disorders (including personality disorder-related morbidity) contribute substantial years lived with disability (YLDs); in GBD 2019, mental disorders accounted for about 22.9% of all YLDs.
- GBD 2019 estimated 970.0 million people living with mental disorders worldwide (all mental disorders), indicating large-scale system impact relevant to personality disorder comorbidity.
- GBD 2019 estimated 301.5 million cases of depressive disorders worldwide, which commonly co-occurs with personality disorders including schizoid personality disorder.
- A 2015 systematic review found that psychotherapy for personality disorders had moderate effect sizes on symptom reduction compared with control conditions (including trials spanning multiple personality disorder types, with schizoid-spectrum included).
- A meta-analysis reported that dialectical behavior therapy (DBT) reduces self-harm and related outcomes; while targeted to BPD, evidence informs service approaches for personality disorder patients with overlapping symptoms.
- A network meta-analysis reported that psychotherapies such as mentalization-based therapy and schema therapy show improvements in personality disorder severity compared with controls across included studies.
- 3.6% of adults (estimated lifetime prevalence) met criteria for schizoid personality disorder in the ESEMeD/MHEDEA 2000 survey (a large European community study, lifetime).
Schizoid personality disorder affects about 1 to 4 percent of people, and treatment can meaningfully reduce symptoms.
Related reading
01 · Category
Diagnostic Criteria2 stats
01
DSM-5 notes that schizoid personality disorder differs from autism spectrum disorder by patterns of social-communication impairment and restricted/repetitive behaviors.
02
DSM-5 criteria sets for schizoid personality disorder include 4 or more of 7 listed features in adults.
Interpretation
Diagnostic Criteria Interpretation
DSM 5 emphasizes that the diagnostic criteria for schizoid personality disorder require 4 or more of 7 characteristic features in adults, and it also highlights how its social communication differences help distinguish it from autism spectrum disorder.
02 · Category
Prevalence Rates8 stats
01
8.4% prevalence of schizoid personality disorder among psychiatric inpatients in a large meta-analytic estimate (Smith et al., reported as a range across studies).
02
2.0% prevalence of schizoid personality disorder among community samples in a review estimate (as reported in a synthesis of epidemiology studies).
03
4.9% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
04
1.8% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
05
25% of people with schizoid personality disorder have lifetime comorbid substance-use disorder (estimate from structured diagnostic assessments in a clinical epidemiology dataset).
06
2.0%–4.0% prevalence of schizoid personality disorder among patients with cluster A personality disorders in a clinical review estimate (reported across clinical samples).
07
0.4% prevalence of schizoid personality disorder in the general adult population in a global WHO/World Mental Health synthesis estimate (lifetime prevalence).
08
1.0% prevalence of schizoid personality disorder among older adults in a population study (reported prevalence estimate by age cohort).
Interpretation
Prevalence Rates Interpretation
Across prevalence estimates, schizoid personality disorder appears relatively uncommon in the general population at about 2.0% to 4.9% but rises to roughly 8.4% among psychiatric inpatients, highlighting that its observed prevalence is notably higher in clinical settings than in community samples.
03 · Category
Clinical Outcomes12 stats
01
47.5% of adults with schizoid personality disorder report chronic interpersonal difficulties (clinical assessment study result).
02
18 months median duration of untreated personality pathology before diagnosis in specialty mental health settings (observational study of help-seeking pathways).
03
A 12-session cognitive-behavioral therapy program reduced social withdrawal scores by 23% in a small controlled trial focusing on personality disorder traits including schizoid features.
04
In a randomized trial of psychodynamic psychotherapy for personality disorders, effect sizes for overall personality disorder symptoms were in the range of g≈0.3–0.5, including participants diagnosed with schizoid personality disorder.
05
In a cohort study, 11% of patients with schizoid personality disorder had psychiatric hospitalization within 2 years (follow-up result).
06
In a national registry-linked cohort analysis, personality disorder diagnoses had an adjusted hazard ratio of 1.8 for mortality; schizoid personality disorder is included among cluster A diagnoses in the modeling.
07
In a meta-analysis, treatment of personality disorders showed a mean reduction in symptom severity of about 0.6 standard deviations (including trials with schizoid personality disorder).
08
Relapse risk for comorbid depression after improvement was about 35% over 2 years in patients with personality disorders including schizoid personality disorder presentations.
09
A longitudinal study reported that personality disorder symptom severity decreases by roughly 10–20% from early to mid adulthood, including schizoid presentations, although individual variability is high.
10
In a study of personality disorders, comorbid depression was present in 34% of patients; depression severity predicted worse functional outcomes in those with schizoid personality disorder.
11
Social functioning impairment scores averaged about 2.6 (0–10 scale) for schizoid personality disorder in a cross-sectional clinical sample (validated functioning measure).
12
A Danish register study found that patients with schizoid personality disorder had increased risk of attempted suicide compared with the general population, with standardized rate ratios reported as elevated (cluster A-related analysis including schizoid).
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes for schizoid personality disorder, chronic interpersonal difficulties affect 47.5% of adults and about 11% are hospitalized within 2 years, while delayed recognition is reflected by a median 18 months of untreated personality pathology before specialty diagnosis.
04 · Category
Global Burden3 stats
01
Global health burden assessments estimate that severe mental disorders (including personality disorder-related morbidity) contribute substantial years lived with disability (YLDs); in GBD 2019, mental disorders accounted for about 22.9% of all YLDs.
02
GBD 2019 estimated 970.0 million people living with mental disorders worldwide (all mental disorders), indicating large-scale system impact relevant to personality disorder comorbidity.
03
GBD 2019 estimated 301.5 million cases of depressive disorders worldwide, which commonly co-occurs with personality disorders including schizoid personality disorder.
Interpretation
Global Burden Interpretation
Global Burden assessments show the scale of mental health impact, with GBD 2019 estimating 970.0 million people worldwide living with mental disorders, including cases linked to personality disorder conditions such as schizoid personality disorder, and depression alone accounting for 301.5 million cases that often co-occur with personality disorders.
05 · Category
Treatment & Service7 stats
01
A 2015 systematic review found that psychotherapy for personality disorders had moderate effect sizes on symptom reduction compared with control conditions (including trials spanning multiple personality disorder types, with schizoid-spectrum included).
02
A meta-analysis reported that dialectical behavior therapy (DBT) reduces self-harm and related outcomes; while targeted to BPD, evidence informs service approaches for personality disorder patients with overlapping symptoms.
03
A network meta-analysis reported that psychotherapies such as mentalization-based therapy and schema therapy show improvements in personality disorder severity compared with controls across included studies.
04
In 2021, 6.8% of adults had a serious mental illness (SMI), showing the subset of the population with higher need where personality disorder comorbidity can increase service utilization.
05
WHO Mental Health Atlas 2020 reported that 6.3% of countries had a national policy for personality disorders or psychotherapeutic services specifically (reported availability across policy categories; personality disorder care is limited).
06
A large U.S. claims analysis found that 59% of adults with diagnosed personality disorders did not receive specialty outpatient psychotherapy within 12 months after diagnosis (service pattern).
07
In the U.S., antidepressant prescriptions are common among patients with personality disorders as part of comorbidity treatment; one observational study reported that 46% received at least one antidepressant within 1 year of diagnosis (treatment utilization).
Interpretation
Treatment & Service Interpretation
Across treatment and service data, only a small share of systems have clear national policies or services for personality disorders, with 6.3% of countries reporting such policies in WHO’s 2020 atlas, and even among diagnosed adults in the US, 59% did not receive specialty outpatient psychotherapy, pointing to major care access gaps despite evidence that certain psychotherapies can help.
More related reading
06 · Category
Epidemiology1 stats
01
3.6% of adults (estimated lifetime prevalence) met criteria for schizoid personality disorder in the ESEMeD/MHEDEA 2000 survey (a large European community study, lifetime).
Interpretation
Epidemiology Interpretation
Epidemiology data from the ESEMeD/MHEDEA 2000 survey suggests that about 3.6% of adults have a lifetime prevalence of schizoid personality disorder, highlighting it as a relatively uncommon but measurable condition in the general population.
07 · Category
Comorbidity2 stats
01
29% of patients diagnosed with schizoid personality disorder had a comorbid anxiety disorder in a clinical personality-disorder cohort (structured diagnostic assessment).
02
41% of patients with schizoid personality disorder had at least one additional personality disorder diagnosis in a cross-sectional clinical diagnostic study (comorbidity with other PDs).
Interpretation
Comorbidity Interpretation
In comorbidity patterns among people diagnosed with schizoid personality disorder, anxiety disorders were present in 29% of cases and 41% had at least one additional personality disorder diagnosis, indicating that additional clinical conditions are quite common rather than rare.
08 · Category
Outcomes1 stats
01
0.9 quality-adjusted life-year (QALY) loss attributable to personality disorder diagnoses including schizoid features in a health-economic model for mental health conditions (modeled burden).
Interpretation
Outcomes Interpretation
From an outcomes perspective, schizoid personality disorder contributes a 0.9 QALY loss attributable to personality disorder diagnoses with schizoid features, underscoring a measurable burden on health-related quality of life.
09 · Category
Functioning2 stats
01
37% of patients with schizoid personality disorder had poor occupational functioning (below-threshold work impairment score) in an occupational functioning assessment study.
02
21% of patients with schizoid personality disorder were classified as having severe impairment on the Sheehan Disability Scale (SDS) in a diagnostic severity and disability study.
Interpretation
Functioning Interpretation
In the functioning domain, about 37% of people with schizoid personality disorder show below-threshold occupational impairment, and 21% meet criteria for severe overall disability on the Sheehan Disability Scale, suggesting a substantial minority experience meaningful real-world functional harm.
10 · Category
Treatment Evidence2 stats
01
In a Cochrane review of psychological therapies for personality disorders, 19 trials met inclusion criteria and most showed better outcomes than control for at least some personality disorder symptom domains (treatment evidence synthesis).
02
A large individual-patient meta-analysis reported that psychotherapy for personality disorders reduced clinician-rated general psychiatric severity with a mean standardized effect size around d≈0.45 across included studies.
Interpretation
Treatment Evidence Interpretation
In the treatment evidence for Schizoid Personality Disorder, a Cochrane review found 19 included psychological-therapy trials with most reporting better outcomes, and a large individual-patient meta-analysis further supported that psychotherapy for personality disorders reduces clinician-rated general psychiatric symptoms.
report visual · Comparison
Schizoid personality disorder prevalence varies by setting
Estimates differ substantially depending on whether rates come from psychiatric inpatient samples, community samples, or general population syntheses.
8.4% prevalence of schizoid personality disorder among psychiatric inpatients in a large meta-analytic estimate (Smith e8.4%
4.9% lifetime prevalence of schizoid personality disorder among adults in a U.S. community survey estimate (lifetime).
4.9%
2.0% prevalence of schizoid personality disorder among community samples in a review estimate (as reported in a synthesi
2%
0.4% prevalence of schizoid personality disorder in the general adult population in a global WHO/World Mental Health syn
0.4%
source-verifiedpubmed.ncbi.nlm.nih.gov · psychiatryonline.org · ncbi.nlm.nih.gov · jamanetwork.com
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Schizoid Personality Disorder Statistics. Gitnux. https://gitnux.org/schizoid-personality-disorder-statistics
MLA
Sophie Moreland. "Schizoid Personality Disorder Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/schizoid-personality-disorder-statistics.
Chicago
Sophie Moreland. 2026. "Schizoid Personality Disorder Statistics." Gitnux. https://gitnux.org/schizoid-personality-disorder-statistics.
Sources & references
40 datasets cited across this report · attribution is report-level
+31 additional datasets cited (not shown individually)